The TGA urged doctors to warn Ozempic users to 'be careful' and check the dose before administering it. Earlier this month, ...

Sunday on PBS News Weekend, three years after the end of Roe v. Wade, a decades-old movement is exploring new ways to circumvent abortion bans and restrictions. A former FDA head discusses the science ...

According to the CDC, 1 in 5 American adults is living with obesity. In recent years, many have turned to weight loss drugs containing GLP-1, a hormone that slows digestion and helps with sustained ...

In what she calls the "wild west" of obesity medicines, Missouri-based Amy Spencer is a pioneer.

The Mounjaro weight-loss jab is now available from GPs the NHS, but only for a limited group of patients with a BMI over 35 ...

McCormick & Company, Incorporated (NYSE:MKC) is one of the Jim Cramer Warns Viewers About FOMO & Discusses These 19 Stocks.

GoodRx reports GLP-1 weight-loss pills are emerging, with candidates like orforglipron and oral semaglutide likely to gain FDA approval by 2026.

Liraglutide, a medication commonly used to treat diabetes, has shown promising results in reducing chronic migraine in ...

As the NHS rolls out Mounjaro being prescribed by GPs, weight loss jabs have been linked to potentially fatal side effects in new data ...

Ana had to take the jabs once a week, with the price per month starting at £150, but increasing to £210 as it went up in ...

UnitedHealth Group’s ( UNH) new CEO, Stephen Hemsley, is shaking up the senior management of the company, appointing Patrick Conway, newly named CEO of the managed care giant’s Optum unit, as the head ...